Laboratory Informatics Weekly Update – Volume 18, Issue 26
June 30, 2020 Laboratory Informatics Weekly Update Volume 18, Issue 26 In This Issue Featured Books COVID-19 Testing, Reporting, and Information Management in the Laboratory Featured Content 06/29/2020 - Customer Specification Matching and Product Regrading with QLIMSProduct variation is a natural effect of manufacturing, the question here is how do you manage product variation in a manner that can improve your business and meet customer specifications. The Answer: Automating the customer specification and product regrading process.This is especially important for organisations that cater to a wide range of customers or export markets that may have different specifications due to preferences…Customer Specification Matching and Product Regrading with QLIMS
Product variation is a natural effect of manufacturing, the question here is how do you manage product variation in a manner that can improve your business and meet customer specifications.[Read More]
3 Considerations for Building a Diagnostic Testing Lab
During the COVID-19 pandemic, the world has developed a renewed interest in, and placed an emphasis on, diagnostics. As a result, new companies and laboratories are being established across the U.S. to support the need for diagnostic testing. In some cases, companies are building brand new facilities from the ground up, while others are setting up diagnostic workflows in biotechnology incubators or other pre-existing laboratory infrastructures.
[Read More]
Lab Informatics Online Courses Now Live from CSols University
In what is planned to be an ever-growing resource for laboratory informatics professionals everywhere, CSols, Inc., the premier laboratory informatics consultancy, has launched CSols University, with its first-ever online course, Creating a Lab Informatics Risk Assessment. This one-hour course is the first to launch this summer, with more to come in the near future.
Remote Capabilities in the World of COVID-19: Laboratory Informatics Roadmap for Encoded Therapeutics
Encoded Therapeutics Inc. (Encoded), a biotechnology company advancing precision medicines for a broad range of genetic disorders. With the increasing need to establish a harmonized laboratory data and process workflow to support the rapid growth of the company, Encoded Therapeutics chose Astrix Technology Group to develop their Informatics Roadmap and Sample Management strategy. However, the COVID-19 pandemic would require a novel new approach to doing business in an unprecedented remote work environment.
[Read More]
Dotmatics Acquires BioBright to Accelerate Laboratory Data Automation for the Lab of the Future
Dotmatics Ltd., a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, has today announced that it has entered into an agreement to acquire BioBright LLC, a leader in automating the flow of data from laboratory instruments to a secure cloud.Eldermark Software Partners with Simply Connect to Enable Automated and Rapid COVID Lab Test Results
MINNETONKA, MINN. (PRWEB) JUNE 24, 2020
Eldermark Software is excited to announce its partnership with Simply Connect to enable automated and fast patient lab testing and test results communication.
The collaboration between Eldermark — the leading senior housing clinical and operational technology — and Simply Connect — Minnesota’s first and only Certified Health Data Intermediary designed for senior care – will allow test outcomes to flow directly to the electronic health record (EHR) for timely review by clinicians.…
Astrix On-Demand Webinar – Planning and Executing a LabVantage LIMS Validation
Validating a Laboratory Information Management System (LIMS) with the many configuration and integration options that are available for LabVantage requires significant project planning and team coordination to execute successfully. [Read More]
Enzyme immunoassay for measuring aflatoxin B1 in legal cannabis
In this 2020 paper published in the journal Toxins, Di Nardo et al. of the University of Turin present their findings from adapting an existing enzyme immunoassay to cannabis testing for purposes of more accurately detecting mycotoxins, including aflatoxins such as aflatoxin B1 (AFB1). Citing benefits such as fewer steps, more cost-efficient equipment, and fewer training level demands, the authors viewed the application of enzyme immunoassay to testing cannabis for mycotoxins a worthy endeavor. Di Nardo et al. discuss at length how they converted an immunoassay for measuring aflatoxins in eggs to one for the cannabis substrate, as well as the various challenges and caveats associated with the resulting methodology. In comparison to techniques such as ultra-high performance liquid chromatography coupled to high resolution tandem mass spectrometry, the authors concluded that enzyme immunoassay more readily allows for "wide applications in low resource settings and for the affordable monitoring of the safety of cannabis products, including those used recreationally and as a food supplement."
Laboratory Informatics Weekly Update – Volume 18, Issue 25
June 23, 2020 Laboratory Informatics Weekly Update Volume 18, Issue 25 In This Issue Featured Books Laboratory Information Management for Cannabis Quality Assurance Featured Content 06/23/2020 - Astrix On-Demand Webinar – Planning and Executing a LabVantage LIMS ValidationValidating a Laboratory Information Management System (LIMS) with the many configuration and integration options that are available for LabVantage requires significant project planning and team coordination to execute successfully. [Read More] 06/22/2020 - LabLynx Announces C-SIC Kit Release LabLynx, Inc. today announced an important new component in its overall COVIDLiMS informatics solution for laboratories, designed to offer faster, more accurate coronavirus testing as well…LabLynx Announces C-SIC Kit Release
LabLynx, Inc. today announced an important new component in its overall COVIDLiMS informatics solution for laboratories, designed to offer faster, more accurate coronavirus testing as well as ongoing risk management for businesses and organizations. The C-SIC (COVID-Sample Information Collection) kit accurately captures specimen and patient information and ensures it is included on the sample label, preventing errors during sampling and transport.
[Read More]
Labware LIMS Developer
We have been looking out for a Labware LIMS Developer/ Tech Support candidate for a leading MNC in Bangalore. We need an immediate joiner.
Exp: 5+ yrs
Experience in administering LAB Systems applications like Caliber LIMS/Chromeleon –
Agila/Empower 2 – Carole Park/LabWare LIMS application, LabVantage v 6 & Above
Web Page creation and Configuration
Adhoc-Queries
Advanced Storage and Logistics Module
Languages: JAVA EE 7(EJB 3.1, JPA)
Databases: Oracle9i/10g/11g,SQLServer 2005/2008/2014
Interested please share your profile with rekha.m@sonyocareers.com…
Labware LIMS Developer
We have been looking out for a Labware LIMS Developer/ Tech Support candidate for a leading MNC in Bangalore. We need an immediate joiner.
Exp: 5+ yrs
Experience in administering LAB Systems applications like Caliber LIMS/Chromeleon –
Agila/Empower 2 – Carole Park/LabWare LIMS application, LabVantage v 6 & Above
Web Page creation and Configuration
Adhoc-Queries
Advanced Storage and Logistics Module
Languages: JAVA EE 7(EJB 3.1, JPA)
Databases: Oracle9i/10g/11g,SQLServer 2005/2008/2014
Interested please share your profile with rekha.m@sonyocareers.com…
The regulatory landscape of precision oncology laboratory medicine in the United States: Perspective on the past five years and considerations for future regulation
What is the current status of laboratory developed tests (LDTs) and the U.S. Food and Drug Administration's (FDA) approach to them? What are the arguments for and against their regulation? In this 2020 review article published in Practical Laboratory Medicine, University of Washington's Eric Konnick covers the current U.S. regulatory environment for LDTs, as well as recent developments since the October 2014 FDA release of LDT draft guidance. Konnick then provides extensive commentary on the scope of LDT regulation in the U.S., including perceived risks to patients, LDT accuracy and equivalency, and how regulatory certainty fits into LDT innovation. He closes with recommendations for approaching future LDT regulation, concluding that "identifying tools that can be leveraged to improve laboratory test quality may offer many benefits that do not necessarily require a burdensome regulatory framework."
ACD/Labs’ Educational Software Package for Drawing Chemical Structures Achieves Key Milestone
ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced that ACD/ChemSketch Freeware has been downloaded by over two million users worldwide.How to Ensure Value from your Lab Informatics Implementation
[Read More]
Abbott Informatics Plays Integral Role in Supporting the Public Health COVID-19 Response
STARLIMS PH has enabled CDC and other public health agencies to reduce test turnaround time, eliminate the manual data entry process, and increase the throughput for testing during the during the COVID-19 pandemic.
SCC adds new product to our Research Information System Suite product catalogue
After 40 years our primary focus remains to provide laboratories with world-wide powerful and flexible software tools enabling them to compete in a highly competitive clinical diagnostics marketplace. Applying technology to create the most advanced—and most cost-effective—healthcare IT solutions continues to be our strategy as we introduce SoftBiobank™ to our Research Information Systems Suite.
[Read More]
How Labs and Businesses Can Work Together to Reopen Safely
As the nations of the world begin transitioning from flattening the curve to cautiously beginning to resume doing business, the focus is turning to how best to prevent a “second wave” - and in fact to operate over the long term in the face of potential similar pandemics. Experts tell us this may only be the beginning, and that the likelihood is that new zoonotic viruses will arise with increasing frequency as we continue to disrupt natural habitats to accommodate the ever-increasing human population.
